Lenalidomide is indicated for adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal···【Read More】
Update: 2026-05-20Source: Haiou HealthViews: 138
Lenalidomide is a drug used to treat multiple myeloma and myelodysplastic syndromes, and it has gradually gained attention in the Chinese market in re···【Read More】
Update: 2026-05-20Source: Haiou HealthViews: 131
Lenalidomide is a targeted drug used to treat multiple myeloma and myelodysplastic syndromes. Many patients are concerned about the quantity and price···【Read More】
Update: 2026-05-20Source: Haiou HealthViews: 128
Lenalidomide can be used in combination with dexamethasone to treat adult patients with multiple myeloma (MM). The dosage and cost of treatment are co···【Read More】
Update: 2026-05-19Source: Haiou HealthViews: 145
Indications1. Multiple Myeloma (MM)Newly diagnosed patients: Maintenance therapy after autologous hematopoietic stem cell transplantation (ASCT).Patie···【Read More】
Update: 2026-05-19Source: Haiou HealthViews: 132
Lenalidomide is an oral immunomodulator developed by Celgene Corporation, primarily used to treat hematologic malignancies such as multiple myeloma, m···【Read More】
Update: 2026-05-19Source: Haiou HealthViews: 121
Indications1. Multiple Myeloma (MM)Newly diagnosed patients: Maintenance therapy after autologous hematopoietic stem cell transplantation (ASCT).Patie···【Read More】
Update: 2026-05-19Source: Haiou HealthViews: 122
Lenalidomide is an oral immunomodulator developed by Celgene Corporation, primarily used to treat hematologic malignancies such as multiple myeloma, m···【Read More】
Update: 2026-05-19Source: Haiou HealthViews: 120
Pomalidomide is a small-molecule immunomodulatory drug that exerts its therapeutic effects by inhibiting tumor cell proliferation, inducing tumor cell···【Read More】
Update: 2026-05-15Source: Haiou HealthViews: 153
Pomalidomide is an oral immunomodulatory prescription drug, commonly available in capsule form. It works by regulating the immune system to inhibit tu···【Read More】
Update: 2026-05-15Source: Haiou HealthViews: 136
Bedaquiline is a diarylquinoline antimycobacterial drug specifically used to treat a particular type of pulmonary tuberculosis. As a prescription drug···【Read More】
Update: 2026-05-13Source: Haiou HealthViews: 143
Bedaquiline is a diarylquinoline antibacterial prescription drug, commonly available in tablet form. It works by inhibiting the ATP synthase in Mycoba···【Read More】
Update: 2026-05-13Source: Haiou HealthViews: 175
Encorafenib is a targeted therapy drug designed for cancer patients harboring BRAF V600E or V600K mutations. It is frequently used in combination with···【Read More】
Update: 2026-05-12Source: Haiou HealthViews: 140
Encorafenib is a targeted therapy drug designed for cancer patients harboring BRAF V600E or V600K mutations. It is typically used in combination with ···【Read More】
Update: 2026-05-12Source: Haiou HealthViews: 157
On June 27, 2018, the U.S. Food and Drug Administration (FDA) approved the combination regimen of Binimetinib and Encorafenib for the treatment of pat···【Read More】
Update: 2026-05-12Source: Haiou HealthViews: 169
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos